<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04627818</url>
  </required_header>
  <id_info>
    <org_study_id>B6702020000011</org_study_id>
    <nct_id>NCT04627818</nct_id>
  </id_info>
  <brief_title>Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies</brief_title>
  <acronym>MULAN</acronym>
  <official_title>Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies: a Prospective Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to get a better understanding of the clinical implications&#xD;
      (including reproductive problems and obstetric complications), appropriate diagnostic tools&#xD;
      and correct surgical treatment of Mullerian anomalies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mullerian anomalies are rare, therefore they are not well known and not often considered as&#xD;
      differential diagnosis. This causes a delay in the diagnosis with risk of long lasting&#xD;
      symptoms and adverse effects on the reproductive function. However, the diagnosis can be made&#xD;
      more accurately with improved diagnostic tools. Moreover, minimally invasive surgery allows&#xD;
      for preservation and potential improvement of fertility in these women.&#xD;
&#xD;
      The purpose of this study is to get a better understanding of the clinical implications&#xD;
      (including reproductive problems and obstetric complications), appropriate diagnostic tools&#xD;
      and correct surgical treatment of Mullerian anomalies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2050</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fertility</measure>
    <time_frame>10 years after trying to conceive</time_frame>
    <description>Time to clinical pregnancy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fertility</measure>
    <time_frame>18 weeks after conception</time_frame>
    <description>Early pregnancy loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical approach</measure>
    <time_frame>During surgery</time_frame>
    <description>Different surgical approaches used</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical success</measure>
    <time_frame>15 years after surgery</time_frame>
    <description>Relief of symptoms after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy</measure>
    <time_frame>at the time of diagnostic workup</time_frame>
    <description>The ability of a test to detect a Mullerian variation when it is present and detect the absence of a Mullerian variation when it is absent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstetric complications</measure>
    <time_frame>1 year after conception</time_frame>
    <description>Complications during pregnancy, labor, delivery, and the postpartum period</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Mullerian Anomaly of Uterus, Nec</condition>
  <condition>Mullerian Anomaly of Vagina</condition>
  <condition>Mullerian Anomaly of Cervix</condition>
  <arm_group>
    <arm_group_label>patients with a mullerian variation</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        diagnosed and/or treated in the Ghent University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women with a uterus&#xD;
&#xD;
          -  presence of a mullerian variation&#xD;
&#xD;
          -  Maximum age 45y&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  women without a uterus&#xD;
&#xD;
          -  aged &gt;45y&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women with a uterus</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tjalina Hamerlynck</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eline Meireson</last_name>
    <phone>093327817</phone>
    <phone_ext>0032</phone_ext>
    <email>eline.meireson@uzgent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ghent University hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eline Meireson</last_name>
      <phone>+3193327817</phone>
      <email>eline.meireson@uzgent.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2020</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mullerian anomaly</keyword>
  <keyword>Diagnostic tools</keyword>
  <keyword>Surgical treatment</keyword>
  <keyword>Reproductive function</keyword>
  <keyword>Obstetric complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

